Difference between revisions of "Adult granulosa cell tumour"
Jump to navigation
Jump to search
(redirect for now) |
(split out) |
||
| Line 1: | Line 1: | ||
'''Adult granulosa cell tumour''' is an [[ovarian tumour]]. It is also known as '''granulosa cell tumour'''. It dhould '''not''' be confused with the ''[[granular cell tumour]]''. | |||
Ideally, it should be called ''adult granulosa cell tumour'' to avoid confusion with ''[[juvenile granulosa cell tumour]]''. | |||
==General== | |||
*May secrete estrogen. | |||
**May present with endometrial pathology, e.g. [[endometrial hyperplasia]] ''or'' endometrioid [[endometrial carcinoma]]. | |||
**Occasionally secrete antrogens lead to virilization.<ref name=pmid19062005>{{Cite journal | last1 = Patel | first1 = SS. | last2 = Carrick | first2 = KS. | last3 = Carr | first3 = BR. | title = Virilization persists in a woman with an androgen-secreting granulosa cell tumor. | journal = Fertil Steril | volume = 91 | issue = 3 | pages = 933.e13-5 | month = Mar | year = 2009 | doi = 10.1016/j.fertnstert.2008.10.038 | PMID = 19062005 }}</ref> | |||
Note: | |||
*Normal granulosa cells convert androgen from the theca cells to estrogen and/or progesterone.<ref name=pmid15541573>{{Cite journal | last1 = Havelock | first1 = JC. | last2 = Rainey | first2 = WE. | last3 = Carr | first3 = BR. | title = Ovarian granulosa cell lines. | journal = Mol Cell Endocrinol | volume = 228 | issue = 1-2 | pages = 67-78 | month = Dec | year = 2004 | doi = 10.1016/j.mce.2004.04.018 | PMID = 15541573 }}</ref> | |||
==Gross== | |||
*Classically solid. | |||
==Microscopic== | |||
Features: | |||
* Classic appearance includes gland-like structures filled with acidophilic material (Call-Exner bodies). | |||
* Small cuboidal to polygonal cell in sheets ''or'' strands ''or'' cords. | |||
* Nuclear grooves. | |||
Note: | |||
*There is a "10% rule" -- if less than 10% of a SCST is granulosa cells... it isn't granulosa cell tumour. | |||
*Juvenile variant of GCT has more nuclear pleomorphism. | |||
DDx:<ref>{{Cite journal | last1 = Kommoss | first1 = S. | last2 = Anglesio | first2 = MS. | last3 = Mackenzie | first3 = R. | last4 = Yang | first4 = W. | last5 = Senz | first5 = J. | last6 = Ho | first6 = J. | last7 = Bell | first7 = L. | last8 = Lee | first8 = S. | last9 = Lorette | first9 = J. | title = FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines. | journal = Mod Pathol | volume = 26 | issue = 6 | pages = 860-7 | month = Jun | year = 2013 | doi = 10.1038/modpathol.2012.226 | PMID = 23348906 }}</ref> | |||
* [[Urothelial cell carcinoma]] (UCC). | |||
** UCC usually has extensive necrosis. | |||
* [[Brenner tumour]]. | |||
* [[Sertoli cell tumour]]. | |||
* [[Sertoli-Leydig cell tumour]]. | |||
* [[Endometrial stromal sarcoma]]. | |||
===Images=== | |||
<gallery> | |||
Image:Granulosa_cell_tumour1.jpg | Granulosa cell tumour - low mag. (WC) | |||
Image:Granulosa_cell_tumour2.jpg | Granulosa cell tumour - high mag. (WC) | |||
</gallery> | |||
==IHC== | |||
* Inhibin positive.<ref name=Ref_PBoD1102>{{Ref PBoD|1102}}</ref> | |||
** Inhibin negative in ''[[Brenner tumour]]''. | |||
*Calretinin +ve. | |||
==Molecular== | |||
:Currently not used for diagnosis. | |||
*FOXL2 point mutation<ref name=pmid22240241 >{{Cite journal | last1 = Jamieson | first1 = S. | last2 = Fuller | first2 = PJ. | title = Molecular pathogenesis of granulosa cell tumors of the ovary. | journal = Endocr Rev | volume = 33 | issue = 1 | pages = 109-44 | month = Feb | year = 2012 | doi = 10.1210/er.2011-0014 | PMID = 22240241 }}</ref> seen in 86 of 89 tumours.<ref name=pmid19516027>{{Cite journal | last1 = Shah | first1 = SP. | last2 = Köbel | first2 = M. | last3 = Senz | first3 = J. | last4 = Morin | first4 = RD. | last5 = Clarke | first5 = BA. | last6 = Wiegand | first6 = KC. | last7 = Leung | first7 = G. | last8 = Zayed | first8 = A. | last9 = Mehl | first9 = E. | title = Mutation of FOXL2 in granulosa-cell tumors of the ovary. | journal = N Engl J Med | volume = 360 | issue = 26 | pages = 2719-29 | month = Jun | year = 2009 | doi = 10.1056/NEJMoa0902542 | PMID = 19516027 }}</ref> | |||
==See also== | |||
*[[Ovarian tumours]]. | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Ovarian tumours]] | |||
[[Category:Diagnosis]] | [[Category:Diagnosis]] | ||
Revision as of 23:42, 18 October 2014
Adult granulosa cell tumour is an ovarian tumour. It is also known as granulosa cell tumour. It dhould not be confused with the granular cell tumour.
Ideally, it should be called adult granulosa cell tumour to avoid confusion with juvenile granulosa cell tumour.
General
- May secrete estrogen.
- May present with endometrial pathology, e.g. endometrial hyperplasia or endometrioid endometrial carcinoma.
- Occasionally secrete antrogens lead to virilization.[1]
Note:
- Normal granulosa cells convert androgen from the theca cells to estrogen and/or progesterone.[2]
Gross
- Classically solid.
Microscopic
Features:
- Classic appearance includes gland-like structures filled with acidophilic material (Call-Exner bodies).
- Small cuboidal to polygonal cell in sheets or strands or cords.
- Nuclear grooves.
Note:
- There is a "10% rule" -- if less than 10% of a SCST is granulosa cells... it isn't granulosa cell tumour.
- Juvenile variant of GCT has more nuclear pleomorphism.
DDx:[3]
- Urothelial cell carcinoma (UCC).
- UCC usually has extensive necrosis.
- Brenner tumour.
- Sertoli cell tumour.
- Sertoli-Leydig cell tumour.
- Endometrial stromal sarcoma.
Images
Granulosa cell tumour - low mag. (WC)
Granulosa cell tumour - high mag. (WC)
IHC
- Inhibin positive.[4]
- Inhibin negative in Brenner tumour.
- Calretinin +ve.
Molecular
- Currently not used for diagnosis.
See also
References
- ↑ Patel, SS.; Carrick, KS.; Carr, BR. (Mar 2009). "Virilization persists in a woman with an androgen-secreting granulosa cell tumor.". Fertil Steril 91 (3): 933.e13-5. doi:10.1016/j.fertnstert.2008.10.038. PMID 19062005.
- ↑ Havelock, JC.; Rainey, WE.; Carr, BR. (Dec 2004). "Ovarian granulosa cell lines.". Mol Cell Endocrinol 228 (1-2): 67-78. doi:10.1016/j.mce.2004.04.018. PMID 15541573.
- ↑ Kommoss, S.; Anglesio, MS.; Mackenzie, R.; Yang, W.; Senz, J.; Ho, J.; Bell, L.; Lee, S. et al. (Jun 2013). "FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines.". Mod Pathol 26 (6): 860-7. doi:10.1038/modpathol.2012.226. PMID 23348906.
- ↑ Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 1102. ISBN 0-7216-0187-1.
- ↑ Jamieson, S.; Fuller, PJ. (Feb 2012). "Molecular pathogenesis of granulosa cell tumors of the ovary.". Endocr Rev 33 (1): 109-44. doi:10.1210/er.2011-0014. PMID 22240241.
- ↑ Shah, SP.; Köbel, M.; Senz, J.; Morin, RD.; Clarke, BA.; Wiegand, KC.; Leung, G.; Zayed, A. et al. (Jun 2009). "Mutation of FOXL2 in granulosa-cell tumors of the ovary.". N Engl J Med 360 (26): 2719-29. doi:10.1056/NEJMoa0902542. PMID 19516027.